[go: up one dir, main page]

CN102516122A - Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril, DMF solution of 2-hydroxy-benzonitril and application thereof - Google Patents

Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril, DMF solution of 2-hydroxy-benzonitril and application thereof Download PDF

Info

Publication number
CN102516122A
CN102516122A CN201110349880XA CN201110349880A CN102516122A CN 102516122 A CN102516122 A CN 102516122A CN 201110349880X A CN201110349880X A CN 201110349880XA CN 201110349880 A CN201110349880 A CN 201110349880A CN 102516122 A CN102516122 A CN 102516122A
Authority
CN
China
Prior art keywords
salicylonitrile
dmf solution
dmf
eco
friendly preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201110349880XA
Other languages
Chinese (zh)
Other versions
CN102516122B (en
Inventor
叶光武
张小兵
赵凌鹄
汪青松
张万贞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Heben Pharmaceutical Co ltd
Original Assignee
Shanghai Heben-Eastsun Medicaments Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Heben-Eastsun Medicaments Co Ltd filed Critical Shanghai Heben-Eastsun Medicaments Co Ltd
Priority to CN201110349880.XA priority Critical patent/CN102516122B/en
Publication of CN102516122A publication Critical patent/CN102516122A/en
Application granted granted Critical
Publication of CN102516122B publication Critical patent/CN102516122B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses an environment friendly method for preparing a DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril, which is characterized in that triphosgene and salicylamide are respectively added into DMF to be fully reacted. With the preparation method disclosed by the invention, more than 98% of 2-hydroxy-benzonitril (excluding solvent) can be obtained, the chemical conversion and the selectivity are both greater than 98%, and no problems exist if the 2-hydroxy-benzonitril is directly applied for the next step of reaction. In the process of production, no polluting waste gas and waste water are discharged, scraps are inorganic salts which can directly used or organic amine hydrochlorides which can be recycled, the comprehensive production cost of the 2-hydroxy-benzonitril is greatly reduced, and the production process is environment friendly.

Description

环境友好的制备邻羟基苯甲腈的DMF溶液的方法、邻羟基苯甲腈的DMF溶液及其应用Environmentally friendly method for preparing DMF solution of o-hydroxybenzonitrile, DMF solution of o-hydroxybenzonitrile and application thereof

技术领域 technical field

本发现涉及一种环境友好的制备邻羟基苯甲腈的DMF溶液的方法、邻羟基苯甲腈的DMF溶液及其应用。  The discovery relates to an environmentally friendly method for preparing a DMF solution of o-hydroxybenzonitrile, a DMF solution of o-hydroxybenzonitrile and applications thereof. the

背景技术 Background technique

邻羟基苯甲腈,俗名水杨腈,又名2-羟基苯甲腈、邻羟基苯腈、2-氰基苯酚等,分子式C7H5NO,CAS登记号611-20-1,具有一定水溶性,Pka=7.17,对强碱和氧化剂不稳定。作为医药中间体可以合成治疗高血压和心绞痛药物盐酸布尼洛尔,作为农药中间体,可以合成杀菌剂嘧菌酯,另外还可以合成多种香料和液晶材料等。  O-hydroxybenzonitrile, commonly known as salicylonitrile, also known as 2-hydroxybenzonitrile, o-hydroxybenzonitrile, 2-cyanophenol, etc., molecular formula C7H5NO, CAS registration number 611-20-1, has certain water solubility, Pka =7.17, unstable to strong bases and oxidants. As a pharmaceutical intermediate, it can be used to synthesize Bunirolol hydrochloride, a drug for treating hypertension and angina pectoris. As a pesticide intermediate, it can be used to synthesize the fungicide azoxystrobin. In addition, it can also synthesize a variety of spices and liquid crystal materials. the

水杨酰胺,白色或微粉红色结晶性粉末。熔点140℃。水杨酰胺易溶于热水、醇、醚和氯仿,微溶于冷水。28℃饱和水溶液的pH约为5。水杨酰胺略有苦味。解热镇痛药,也用于制取邻乙氧基苯酰胺(即止痛灵)等药物。  Salicylamide, white or slightly pink crystalline powder. The melting point is 140°C. Salicylamide is easily soluble in hot water, alcohol, ether and chloroform, slightly soluble in cold water. The pH of a saturated aqueous solution at 28°C is about 5. Salicylamide has a slightly bitter taste. Antipyretic and analgesic drugs are also used to prepare drugs such as o-ethoxybenzamide (ie Zhitongling). the

制备邻羟基苯甲腈的研究资料比较多,但是具有规模生产价值的不多,主要有:(1)水杨醛和羟胺制得肟,然后脱水得到产品,US5637750,CN201010106946;(2)水杨酰胺一步脱水得到产品,采用固定床催化高温脱水,收率87%,适合千吨级以上连续化大规模生产,US6248917;(3)水杨酸铵(或者水杨酸和氨气混合)脱水得到产品,US7629486,CN201110058467。关于各种方法的优缺点CN201110058467介绍得比较详细,这里需要补充的是:(1)从生 产成本角度来看,只有水杨酰胺或者水杨酸铵脱水制备邻羟基苯甲腈具有明显优势;(2)从市场需求来看,目前年需求量预计在1000吨左右,采用连续化生产设备投入大,技术稳定性需要长时间的可靠性实验验证才能真正实现规模化生产。因此用水杨酰胺脱水法制备邻羟基苯甲腈是比较适合规模化生产的方法。  There are many research materials on the preparation of o-hydroxybenzonitrile, but there are not many with large-scale production value, mainly including: (1) salicylaldehyde and hydroxylamine to obtain oxime, and then dehydrate to obtain the product, US5637750, CN201010106946; (2) salicylaldehyde The product is obtained by one-step dehydration of the amide, and the high-temperature dehydration is catalyzed by a fixed bed, and the yield is 87%, which is suitable for continuous large-scale production of more than 1,000 tons, US6248917; (3) dehydration of ammonium salicylate (or a mixture of salicylic acid and ammonia) to obtain Products, US7629486, CN201110058467. The advantages and disadvantages of various methods CN201110058467 are introduced in more detail, and what needs to be added here is: (1) from the perspective of production cost, only salicylamide or ammonium salicylate dehydration to prepare o-hydroxybenzonitrile has obvious advantages; (2) From the perspective of market demand, the current annual demand is expected to be around 1,000 tons. Continuous production equipment requires a large investment, and technical stability requires long-term reliability test verification to truly realize large-scale production. Therefore, the dehydration method of salicylamide to prepare o-hydroxybenzonitrile is a method suitable for large-scale production. the

运用酰胺脱水方法制备腈类化合物是有机合成中的基本方法,参见《Comprehensive Organic Transformations》中的章节“Amides to Nitriles”,作者Richard C.Larock。常见的方法有:(1)氯化亚砜、三氯氧磷、五氯化磷、光气、五氧化二磷、酸酐和酰氯等类似强力脱水剂直接脱水法;(2)HMPA辅助脱水,Canadian Journal of Chemistry,1971,49,2897;(3)路易斯酸四氯化钛/三乙胺,三氯化铝/碘化钾等非常规试剂。其中具有工业化前景的是第一类,考虑到分子中具有邻位羟基,使用五氧化二磷、酸酐和酰氯等容易得到其它副产物而非邻羟基苯甲腈。氯化亚砜、三氯氧磷、五氯化磷和光气在实际生产过程中由于其毒性、极其怕潮湿和其它原因而在实际生产中难以满足现代环境友好和安全化工生产过程的要求。  The use of amide dehydration method to prepare nitrile compounds is a basic method in organic synthesis, see the chapter "Amides to Nitriles" in "Comprehensive Organic Transformations", author Richard C. Larock. The common methods are: (1) direct dehydration method of strong dehydrating agents such as thionyl chloride, phosphorus oxychloride, phosphorus pentachloride, phosgene, phosphorus pentoxide, acid anhydride and acid chloride; (2) HMPA assisted dehydration, Canadian Journal of Chemistry, 1971, 49, 2897; (3) Lewis acid titanium tetrachloride/triethylamine, aluminum trichloride/potassium iodide and other unconventional reagents. Among them, the first type has industrial prospects. Considering that there is an ortho hydroxyl group in the molecule, it is easy to obtain other by-products instead of o-hydroxybenzonitrile by using phosphorus pentoxide, acid anhydride and acid chloride. Thionyl chloride, phosphorus oxychloride, phosphorus pentachloride and phosgene are difficult to meet the requirements of modern environment-friendly and safe chemical production processes in actual production due to their toxicity, extreme fear of moisture and other reasons. the

黄山等报道了用三光气和水杨酰胺脱水制备水杨腈的技术(山西化工,2009,29,4),水杨酰胺和三光气在甲苯中100-105℃反应,粗品用甲苯重结晶,虽然小试给出了90%左右的收率,但是在实际工业化生产过程中收率不高,产品质量难以提升,很难超过95%,杂质多,影响后续产品的生产,导致嘧菌酯的合成很难得到高品质的产品。虽然粗品邻羟基苯甲腈多次纯化以后虽然能达到98%以上含量,但是生产成本大幅上升,没有实际意义。  Huang Shan et al. reported the technology of preparing salicylonitrile by dehydration of triphosgene and salicylamide (Shanxi Chemical Industry, 2009, 29, 4). Salicylamide and triphosgene were reacted in toluene at 100-105°C, and the crude product was recrystallized with toluene. Although the small test gives a yield of about 90%, the yield is not high in the actual industrial production process, the product quality is difficult to improve, it is difficult to exceed 95%, and there are many impurities, which affect the production of subsequent products and lead to the failure of azoxystrobin. Synthesis is difficult to obtain high-quality products. Although the crude product o-hydroxybenzonitrile can reach a content of more than 98% after multiple purifications, the production cost has risen sharply, which has no practical significance. the

发明内容 Contents of the invention

本发明的目的是为了克服现有技术中的不足,提供一种环境友好的制备邻 羟基苯甲腈的DMF溶液的方法。  The purpose of the present invention is in order to overcome the deficiencies in the prior art, and a kind of method for the DMF solution of the preparation o-hydroxybenzonitrile of environmental friendliness is provided. the

为实现上述目的,本发明通过以下技术方案实现:  To achieve the above object, the present invention is realized through the following technical solutions:

一种环境友好的制备邻羟基苯甲腈的DMF溶液的方法,其特征在于,将三光气和水杨酰胺分别加入DMF中,充分反应。  An environment-friendly method for preparing a DMF solution of o-hydroxybenzonitrile is characterized in that triphosgene and salicylamide are respectively added to DMF for full reaction. the

优选地是,所述的水杨酰胺与三光气的物质的量比为1∶0.33~1.0。  Preferably, the molar ratio of salicylamide to triphosgene is 1:0.33-1.0. the

优选地是,所述的水杨酰胺与三光气的物质的量比为1∶0.34~0.5。  Preferably, the molar ratio of salicylamide to triphosgene is 1:0.34-0.5. the

考虑到反应条件下不可能严格除水,而且一般使用的工业级溶剂和原料中有少量水,适当提高三光气用量是必须的,但是过多使用三光气并不影响邻羟基苯甲腈的收率,综合而言,三光气的用量为水杨酰胺的物质的量的0.34-0.5比较经济。  Considering that it is impossible to strictly remove water under the reaction conditions, and there is a small amount of water in the industrial-grade solvents and raw materials generally used, it is necessary to increase the amount of triphosgene appropriately, but excessive use of triphosgene does not affect the recovery of o-hydroxybenzonitrile. Generally speaking, the amount of triphosgene is 0.34-0.5 of the amount of salicylamide, which is more economical. the

优选地是,反应温度为-20~50℃。  Preferably, the reaction temperature is -20-50°C. the

优选地是,反应温度为5℃~15℃。  Preferably, the reaction temperature is 5°C to 15°C. the

温度太低,能耗较高,温度超过50℃副产物较多,影响产品质量。因此,实际制备时,只要温度不低于5℃、不高于15℃;对其反应温度可不进行干预,如果超出此温度范围,需要对其降温或升温。  If the temperature is too low, the energy consumption is high, and the by-products are more when the temperature exceeds 50°C, which affects the product quality. Therefore, in the actual preparation, as long as the temperature is not lower than 5°C and not higher than 15°C; the reaction temperature does not need to be intervened. If it exceeds this temperature range, it needs to be cooled or heated. the

优选地是,先在DMF中加入三光气,再加入水杨酰胺。  Preferably, triphosgene is added to DMF first, and then salicylamide is added. the

优选地是,所述三光气先溶于惰性溶剂,再加入至DMF中。  Preferably, the triphosgene is firstly dissolved in an inert solvent, and then added into DMF. the

优选地是,先在DMF中加入水杨酰胺,再加入三光气。  Preferably, salicylamide is firstly added in DMF, and then triphosgene is added. the

优选地是,三光气溶解于惰性溶剂后再一并加入溶有水杨酰胺的DMF中。  Preferably, triphosgene is dissolved in an inert solvent and then added to the DMF dissolved in salicylamide. the

优选地是,其特征在于,所述的惰性溶剂选自烃类、醚类、酮类或酯类惰 性溶剂。  Preferably, it is characterized in that the inert solvent is selected from hydrocarbons, ethers, ketones or ester inert solvents. the

优选地是,所述烃类惰性溶剂选自烷烃、芳香烃或其取代衍生物。  Preferably, the hydrocarbon inert solvent is selected from alkanes, aromatic hydrocarbons or substituted derivatives thereof. the

优选地是,所述醚类惰性溶剂选自脂肪醚、芳烃醚或其取代衍生物。  Preferably, the ether inert solvent is selected from aliphatic ethers, aromatic ethers or substituted derivatives thereof. the

优选地是,所述酮类惰性溶剂选自低级脂肪酮或其取代衍生物。  Preferably, the ketone inert solvent is selected from lower aliphatic ketones or substituted derivatives thereof. the

优选地是,所述酯类惰性溶剂选自脂肪酸酯、芳香酸酯或其取代衍生物。  Preferably, the ester inert solvent is selected from fatty acid esters, aromatic acid esters or substituted derivatives thereof. the

优选地是,反应完成后,加入碱中和、过滤得到邻羟基苯甲腈的DMF溶液。  Preferably, after the reaction is completed, add alkali to neutralize and filter to obtain a DMF solution of o-hydroxybenzonitrile. the

优选地是,所述的碱包括无机碱和有机碱中的一种或其混合物。  Preferably, the base includes one or a mixture of inorganic bases and organic bases. the

优选地是,所述无机碱包括碱金属或碱土金属的氧化物、氢氧化物、碳酸盐、碳酸氢盐中的一种或几种。如氨气、氢氧化锂、碳酸锂、氢氧化钠、碳酸钠、碳酸氢钠、氢氧化钾、碳酸钾、碳酸氢钾、氧化镁、氢氧化镁、碳酸镁、氧化钙、氢氧化钙、碳酸钙、碳酸氢钙等或者其混合物。  Preferably, the inorganic base includes one or more of oxides, hydroxides, carbonates and bicarbonates of alkali metals or alkaline earth metals. Such as ammonia, lithium hydroxide, lithium carbonate, sodium hydroxide, sodium carbonate, sodium bicarbonate, potassium hydroxide, potassium carbonate, potassium bicarbonate, magnesium oxide, magnesium hydroxide, magnesium carbonate, calcium oxide, calcium hydroxide, Calcium carbonate, calcium bicarbonate, etc. or a mixture thereof. the

优选地是,所述有机碱包括三乙胺、二乙胺和苯胺中的一种或几种。如三乙胺、三丁胺、二乙基异丙基胺、乌洛托品、三乙烯二胺、苯胺、N-甲基苯胺、N,N-二甲基苯胺等或者其混合物。  Preferably, the organic base includes one or more of triethylamine, diethylamine and aniline. Such as triethylamine, tributylamine, diethylisopropylamine, urotropine, triethylenediamine, aniline, N-methylaniline, N,N-dimethylaniline, etc. or their mixtures. the

本发明采用的是两种方法,第一种方法是先把三光气加入DMF形成Vilsmeier试剂,然后加入水杨酰胺被Vilsmeier试剂脱水形成邻羟基苯甲腈。第二种方法是把三光气加入水杨酰胺的DMF溶液,Vilsmeier试剂作为反应过程的催化剂可以得到同样的结果。  The present invention adopts two methods. The first method is to add triphosgene to DMF to form Vilsmeier reagent, and then add salicylamide to be dehydrated by Vilsmeier reagent to form o-hydroxybenzonitrile. The second method is to add triphosgene to the DMF solution of salicylamide, and Vilsmeier reagent can get the same result as the catalyst of the reaction process. the

DMF的最低用量为三光气的物质的量的6倍,优选地是,DMF的最低用量为三光气的物质的量的6-20倍。其目的是为了控制邻羟基苯甲腈在DMF中的浓度范围在5%-40%。这是因为考虑到实际生产应用的需要,太稀会降低生产效率, 太浓会使产品分离和下一步反应搅拌困难,比较好的是控制浓度范围在15%-25%。这时候DMF大大过量于理论用量,无需考虑反应过程中DMF吸收氯化氢的影响。  The minimum amount of DMF used is 6 times the amount of triphosgene, preferably, the minimum amount of DMF is 6-20 times the amount of triphosgene. Its purpose is to control the concentration of o-hydroxybenzonitrile in DMF in the range of 5%-40%. This is because considering the needs of actual production and application, too thin will reduce production efficiency, and too thick will make product separation and next reaction stirring difficult. It is better to control the concentration range between 15% and 25%. At this time, the DMF is greatly in excess of the theoretical amount, and there is no need to consider the influence of DMF absorbing hydrogen chloride in the reaction process. the

本发明的第二个目的是提供一种邻羟基苯甲腈的DMF溶液,其特征在于,采用前述的方法生产。  Second object of the present invention is to provide a kind of DMF solution of o-hydroxybenzonitrile, it is characterized in that, adopt aforementioned method to produce. the

本发明的第三个目的是提供一种邻羟基苯甲腈,其特征在于,采用前述方法生产的邻羟基苯甲腈的DMF溶液,分离得到邻羟基苯甲腈。  The third object of the present invention is to provide a kind of o-hydroxybenzonitrile, it is characterized in that, adopt the DMF solution of the o-hydroxybenzonitrile produced by aforementioned method, separate and obtain o-hydroxybenzonitrile. the

本发明的第四个目的是提供一种邻羟基苯甲腈的DMF溶液在合成嘧菌酯及布尼洛尔中的应用。本发明中的邻羟基苯甲腈的DMF溶液既可以直接应用于嘧菌酯和盐酸布尼洛尔的合成。也可以用碱来中和后运用于嘧菌酯和盐酸布尼洛尔的合成。  The fourth object of the present invention is to provide the application of a DMF solution of o-hydroxybenzonitrile in the synthesis of azoxystrobin and bunilol. The DMF solution of o-hydroxybenzonitrile in the present invention can be directly applied to the synthesis of azoxystrobin and bunylol hydrochloride. It can also be used in the synthesis of azoxystrobin and Bunirolol hydrochloride after neutralization with alkali. the

本发明中的制备方法可以得到含量大于98%的邻羟基苯甲腈(扣除溶剂),化学转化率和选择性都大于99%,直接应用于下一步反应没有任何问题。在生产过程中没有污染性废气和废水排放,残渣为可以直接利用的无机盐或可以回收利用的有机胺盐酸盐,大幅降低了邻羟基苯甲腈的综合生产成本,是一个环境友好型生产工艺。  The preparation method in the present invention can obtain o-hydroxybenzonitrile (deducting the solvent) with a content greater than 98%, the chemical conversion rate and selectivity are greater than 99%, and there is no problem in directly applying to the next step reaction. In the production process, there is no polluting waste gas and waste water discharge, and the residue is inorganic salt that can be directly used or organic amine hydrochloride that can be recycled, which greatly reduces the comprehensive production cost of o-hydroxybenzonitrile, and is an environmentally friendly production craft. the

具体实施方式 Detailed ways

以下结合实施例对本发明做进一步说明。  The present invention will be further described below in conjunction with embodiment. the

实施例1  Example 1

在冰水混合物冷却下,11.88克(0.04mol)三光气分批次加入到50毫升DMF中。加完后继续搅拌30分钟。控制温度不超过15℃。13.7克水杨酰胺 (0.1mol)分批次加入到上述反应液中,控制温度5-15℃。加料完成后撤去冰水冷却浴,自然升温到室温,继续搅拌一小时,得到邻羟基苯甲腈的DMF溶液。邻羟基苯甲腈含量为98.3%。化学转化率为99.1%;选择性为98.2%。  Under the cooling of the ice-water mixture, 11.88 g (0.04 mol) of triphosgene was added in batches to 50 ml of DMF. Stirring was continued for 30 minutes after the addition was complete. Control the temperature not to exceed 15°C. 13.7 grams of salicylamide (0.1mol) was added to the above reaction solution in batches, and the temperature was controlled at 5-15°C. After the addition was complete, the ice-water cooling bath was removed, the temperature was naturally raised to room temperature, and stirring was continued for one hour to obtain a DMF solution of o-hydroxybenzonitrile. The o-hydroxybenzonitrile content is 98.3%. The chemical conversion rate is 99.1%; the selectivity is 98.2%. the

实施例2  Example 2

在冰水混合物冷却下,11.88克(0.04mol)三光气分批次加入到50毫升DMF中。加完后继续搅拌30分钟。控制温度不超过15℃。13.7克水杨酰胺(0.1mol)分批次加入到上述反应液中,控制温度5-15℃。加料完成后撤去冰水冷却浴,自然升温到室温,继续搅拌一小时;重新用冰水混合物冷却到15℃。加入碳酸钾16.56克(0.12mol),搅拌15分钟后撤去冰水浴,自然升温到室温继续搅拌6小时,过滤得到邻羟基苯甲腈的DMF溶液。邻羟基苯甲腈含量为98.6%。化学转化率为99.4%;选择性为98.4%。  Under the cooling of the ice-water mixture, 11.88 g (0.04 mol) of triphosgene was added in batches to 50 ml of DMF. Stirring was continued for 30 minutes after the addition was complete. Control the temperature not to exceed 15°C. 13.7 g of salicylamide (0.1 mol) was added in batches to the above reaction solution, and the temperature was controlled at 5-15°C. After the addition was complete, the ice-water cooling bath was removed, the temperature was naturally raised to room temperature, and the stirring was continued for one hour; the ice-water mixture was cooled to 15°C again. Add 16.56 g (0.12 mol) of potassium carbonate, stir for 15 minutes, remove the ice-water bath, naturally warm up to room temperature and continue stirring for 6 hours, and filter to obtain a DMF solution of o-hydroxybenzonitrile. The o-hydroxybenzonitrile content is 98.6%. The chemical conversion rate is 99.4%; the selectivity is 98.4%. the

实施例3  Example 3

在冰水混合物冷却下,11.88克(0.04mol)三光气溶解于25毫升乙酸乙酯滴加到50毫升DMF中,加完后继续搅拌30分钟。控制温度不超过15℃。将13.7克水杨酰胺(0.1mol)分批次加入到上述反应液中,控制温度5-15℃。加料完成后撤去冰水冷却浴,自然升温到室温,继续搅拌一小时,旋转蒸发仪减压浓缩蒸除乙酸乙酯得到邻羟基苯甲腈的DMF溶液。邻羟基苯甲腈含量为98.7%。化学转化率为99.5%;选择性为98.5%。  Under the cooling of the ice-water mixture, 11.88 g (0.04 mol) of triphosgene dissolved in 25 ml of ethyl acetate was added dropwise to 50 ml of DMF, and stirring was continued for 30 minutes after the addition was complete. Control the temperature not to exceed 15°C. 13.7 g of salicylamide (0.1 mol) was added in batches to the above reaction solution, and the temperature was controlled at 5-15°C. After the feeding was completed, the ice-water cooling bath was removed, the temperature was naturally raised to room temperature, and the stirring was continued for one hour. The ethyl acetate was distilled off by concentration with a rotary evaporator under reduced pressure to obtain a DMF solution of o-hydroxybenzonitrile. The o-hydroxybenzonitrile content is 98.7%. The chemical conversion rate is 99.5%; the selectivity is 98.5%. the

实施例4  Example 4

在冰水混合物冷却下,11.88克(0.04mol)三光气溶解于25毫升乙酸乙酯 滴加到40毫升DMF中,加完后继续搅拌30分钟。控制温度不超过15℃。13.7克水杨酰胺(0.1mol)溶解于10毫升DMF滴加到上述反应液中,控制温度5-15℃。加料完成后撤去冰水冷却浴,自然升温到室温,继续搅拌一小时;重新用冰水混合物冷却到15℃,加入碳酸钾16.56克(0.12mol),搅拌15分钟后撤去冰水浴,自然升温到室温继续搅拌6小时,过滤,旋转蒸发仪减压浓缩蒸除乙酸乙酯得到邻羟基苯甲腈的DMF溶液。邻羟基苯甲腈含量为98.5%。化学转化率为99.2%;选择性为98.3%。  Under ice-water mixture cooling, 11.88 g (0.04 mol) of triphosgene dissolved in 25 ml of ethyl acetate was added dropwise to 40 ml of DMF, and stirring was continued for 30 minutes after the addition was complete. Control the temperature not to exceed 15°C. 13.7 g of salicylamide (0.1 mol) was dissolved in 10 ml of DMF and added dropwise to the above reaction solution, controlling the temperature at 5-15°C. Remove the ice-water cooling bath after the feeding is completed, naturally warm up to room temperature, and continue to stir for one hour; re-cool to 15°C with ice-water mixture, add 16.56 grams of potassium carbonate (0.12mol), stir for 15 minutes, remove the ice-water bath, and naturally heat up to Continue to stir at room temperature for 6 hours, filter, concentrate under reduced pressure on a rotary evaporator to remove ethyl acetate to obtain a DMF solution of o-hydroxybenzonitrile. The o-hydroxybenzonitrile content is 98.5%. The chemical conversion rate is 99.2%; the selectivity is 98.3%. the

实施例5  Example 5

在冰水混合物冷却下,先将13.7克水杨酰胺(0.1mol)加入50毫升DMF中。再将11.88克(0.04mol)三光气分批次加入,加完后继续搅拌30分钟。控制温度5-15℃。加料完成后撤去冰水冷却浴,自然升温到室温,继续搅拌一小时,得到邻羟基苯甲腈的DMF溶液。邻羟基苯甲腈含量为98.2%。化学转化率为99.1%;选择性为98.3%。  Under the cooling of ice-water mixture, 13.7 g of salicylamide (0.1 mol) was first added into 50 ml of DMF. Then 11.88 g (0.04 mol) of triphosgene was added in batches, and stirring was continued for 30 minutes after the addition was completed. Control temperature 5-15 ℃. After the addition was complete, the ice-water cooling bath was removed, the temperature was naturally raised to room temperature, and stirring was continued for one hour to obtain a DMF solution of o-hydroxybenzonitrile. The o-hydroxybenzonitrile content is 98.2%. The chemical conversion rate is 99.1%; the selectivity is 98.3%. the

实施例6  Example 6

在冰水混合物冷却下,先将13.7克水杨酰胺(0.1mol)加入50毫升DMF中,再分批次加入11.88克(0.04mol)三光气。控制温度5-15℃。加料完成后撤去冰水冷却浴,自然升温到室温,继续搅拌一小时;重新用冰水混合物冷却到15℃,加入碳酸钾16.56克(0.12mol),搅拌15分钟后撤去冰水浴,自然升温到室温继续搅拌6小时,过滤得到邻羟基苯甲腈的DMF溶液。邻羟基苯甲腈含量为98.3%。化学转化率为99.2%;选择性为98.4%。  Under the cooling of the ice-water mixture, 13.7 g of salicylamide (0.1 mol) was first added to 50 ml of DMF, and then 11.88 g (0.04 mol) of triphosgene was added in batches. Control temperature 5-15 ℃. Remove the ice-water cooling bath after the feeding is completed, naturally warm up to room temperature, and continue to stir for one hour; re-cool to 15°C with ice-water mixture, add 16.56 grams of potassium carbonate (0.12mol), stir for 15 minutes, remove the ice-water bath, and naturally heat up to Stirring was continued at room temperature for 6 hours, and a DMF solution of o-hydroxybenzonitrile was obtained by filtration. The o-hydroxybenzonitrile content is 98.3%. The chemical conversion rate is 99.2%; the selectivity is 98.4%. the

实施例7  Example 7

在冰水混合物冷却下,先将13.7克水杨酰胺(0.1mol)加入50毫升DMF中,再将11.88克(0.04mol)三光气溶解于25毫升乙酸乙酯,滴加到水杨酰胺的DMF溶液中,加完后继续搅拌30分钟,控制温度5-15℃。加料完成后撤去冰水冷却浴,自然升温到室温,继续搅拌一小时;重新用冰水混合物冷却到15℃,加入碳酸钾16.56克(0.12mol),搅拌15分钟后撤去冰水浴,自然升温到室温继续搅拌6小时,过滤浓缩乙酸乙酯得到邻羟基苯甲腈的DMF溶液。邻羟基苯甲腈含量为98.5%。化学转化率为99.4%;选择性为98.3%。  Under the cooling of ice-water mixture, first add 13.7 grams of salicylamide (0.1mol) in 50 milliliters of DMF, then dissolve 11.88 grams (0.04mol) of triphosgene in 25 milliliters of ethyl acetate, and add dropwise to the DMF of salicylamide In the solution, continue to stir for 30 minutes after the addition, and control the temperature at 5-15°C. Remove the ice-water cooling bath after the feeding is completed, naturally warm up to room temperature, and continue to stir for one hour; re-cool to 15°C with ice-water mixture, add 16.56 grams of potassium carbonate (0.12mol), stir for 15 minutes, remove the ice-water bath, and naturally heat up to Stirring was continued at room temperature for 6 hours, and ethyl acetate was concentrated by filtration to obtain a DMF solution of o-hydroxybenzonitrile. The o-hydroxybenzonitrile content is 98.5%. The chemical conversion rate is 99.4%; the selectivity is 98.3%. the

应用实施例1  Application Example 1

在实施例1中得到的邻羟基苯甲腈的DMF溶液中,加入32克(0.095mol,含量95%,上海禾本药业有限公司提供)(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯,24.84克(0.18mol)无水碳酸钾,升温到50℃,搅拌一小时;然后继续升温到100-110℃搅拌5小时,减压蒸出DMF,残液冷却到80℃,加入100毫升甲苯和水50毫升;分出甲苯相,用20毫升5%稀盐酸和20毫升饱和碳酸氢钠依次洗涤;浓缩甲苯后得到油状物,用15毫升甲醇重结晶一次得到36克嘧菌酯,含量98.1%(外标法),收率92.2%。  In the DMF solution of o-hydroxybenzonitrile obtained in Example 1, add 32 grams (0.095mol, content 95%, provided by Shanghai Heben Pharmaceutical Co., Ltd.) (E)-2-[2-(6-chloro Pyrimidin-4-yloxy)phenyl]-3-methoxymethyl acrylate, 24.84 grams (0.18mol) of anhydrous potassium carbonate, heated to 50°C, stirred for one hour; then continued to heat up to 100-110°C and stirred After 5 hours, DMF was distilled off under reduced pressure, and the residue was cooled to 80°C, and 100 ml of toluene and 50 ml of water were added; the toluene phase was separated and washed successively with 20 ml of 5% dilute hydrochloric acid and 20 ml of saturated sodium bicarbonate; after concentrating the toluene The oil was obtained, and recrystallized once with 15 ml of methanol to obtain 36 g of azoxystrobin, with a content of 98.1% (external standard method), and a yield of 92.2%. the

应用实施例2  Application Example 2

在实施例2中得到的邻羟基苯甲腈的DMF溶液中,加入32克(0.095mol,含量95%,上海禾本药业提供)(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯,8.28克(0.06mol)无水碳酸钾,升温到100-110℃,搅拌5小时,减压蒸出DMF,残液冷却到80℃,加入100毫升甲苯和水50毫升;分出甲苯相, 用20毫升5%稀盐酸和20毫升饱和碳酸氢钠依次洗涤;浓缩甲苯后得到油状物,用15毫升甲醇重结晶一次得到36.5克嘧菌酯,含量98.5%(外标法),收率93.9%。  In the DMF solution of o-hydroxybenzonitrile obtained in Example 2, add 32 grams (0.095mol, content 95%, provided by Shanghai Heben Pharmaceutical Industry) (E)-2-[2-(6-chloropyrimidine- 4-yloxy)phenyl]-3-methoxymethyl acrylate, 8.28 grams (0.06mol) of anhydrous potassium carbonate, heated to 100-110°C, stirred for 5 hours, evaporated DMF under reduced pressure, and cooled the raffinate To 80°C, add 100 ml of toluene and 50 ml of water; separate the toluene phase, wash it successively with 20 ml of 5% dilute hydrochloric acid and 20 ml of saturated sodium bicarbonate; concentrate the toluene to obtain an oil, and recrystallize once with 15 ml of methanol to obtain 36.5 grams of azoxystrobin, content 98.5% (external standard method), yield 93.9%. the

应用实施例3  Application Example 3

在实施例3中制备的邻羟基苯甲腈DMF溶液中,加入9.25克(0.1mol)环氧氯丙烷,30.36克(0.22mol)无水碳酸钾,升温到80℃搅拌3小时,冷却到室温;加入10.97克(0.15mol)叔丁胺,室温下搅拌6小时,减压蒸除过量的叔丁胺和溶剂DMF,残液加入50毫升乙酸乙酯和15毫升水;分出有机相,用30毫升饱和盐水分两次洗涤,干燥,浓缩得到粗品25克2-[3-(1,1-二甲基乙基氨基)-2-羟基丙氧基]苯甲腈(布尼洛尔),再用85毫升15%氯化氢/乙醇溶液处理得到产品盐酸布尼洛尔26.2克,含量>99%(HPLC),收率91%。  In the o-hydroxybenzonitrile DMF solution prepared in Example 3, add 9.25 grams (0.1mol) of epichlorohydrin, 30.36 grams (0.22mol) of anhydrous potassium carbonate, heat up to 80 ° C and stir for 3 hours, and cool to room temperature Add 10.97 grams (0.15mol) of tert-butylamine, stir at room temperature for 6 hours, evaporate excess tert-butylamine and solvent DMF under reduced pressure, add 50 milliliters of ethyl acetate and 15 milliliters of water to the raffinate; separate the organic phase, and use 30 milliliters of saturated brine Wash twice, dry, and concentrate to obtain 25 grams of crude product 2-[3-(1,1-dimethylethylamino)-2-hydroxypropoxyl]benzonitrile (bunirolol), and then use 85 Milliliters of 15% hydrogen chloride/ethanol solution was processed to obtain 26.2 grams of Bunirolol hydrochloride, the content>99% (HPLC), and the yield was 91%. the

应用实施例4  Application Example 4

在实施例4中制备的邻羟基苯甲腈DMF溶液中,加入9.25克(0.1mol)环氧氯丙烷,13.8克(0.1mol)无水碳酸钾,升温到80℃搅拌3小时,冷却到室温;加入10.97克(0.15mol)叔丁胺,室温下搅拌6小时,减压蒸除过量的叔丁胺和溶剂DMF,残液加入50毫升乙酸乙酯和15毫升水;分出有机相,用30毫升饱和盐水分两次洗涤,干燥,浓缩得到粗品25.3克2-[3-(1,1-二甲基乙基氨基)-2-羟基丙氧基]苯甲腈(布尼洛尔),再用85毫升15%氯化氢/乙醇溶液处理得到产品盐酸布尼洛尔26.7克,含量>99%(HPLC),收率92.8%。  In the o-hydroxybenzonitrile DMF solution prepared in Example 4, add 9.25 grams (0.1mol) of epichlorohydrin, 13.8 grams (0.1mol) of anhydrous potassium carbonate, heat up to 80°C and stir for 3 hours, then cool to room temperature Add 10.97 grams (0.15mol) of tert-butylamine, stir at room temperature for 6 hours, evaporate excess tert-butylamine and solvent DMF under reduced pressure, add 50 milliliters of ethyl acetate and 15 milliliters of water to the raffinate; separate the organic phase, and use 30 milliliters of saturated brine Wash twice, dry, and concentrate to obtain 25.3 grams of crude product 2-[3-(1,1-dimethylethylamino)-2-hydroxypropoxyl]benzonitrile (bunirolol), and then use 85 Milliliters of 15% hydrogen chloride/ethanol solution were treated to obtain 26.7 grams of Bunirolol hydrochloride, the content>99% (HPLC), and the yield was 92.8%. the

应用实施例5  Application Example 5

在实施例5中得到的邻羟基苯甲腈的DMF溶液中,加入32克(0.095mol,含量95%,上海禾本药业提供)(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯,24.84克(0.18mol)无水碳酸钾,升温到50℃,搅拌一小时;然后继续升温到100-110℃搅拌5小时,减压蒸出DMF,残液冷却到80℃,加入100毫升甲苯和水50毫升;分出甲苯相,用20毫升5%稀盐酸和20毫升饱和碳酸氢钠依次洗涤;浓缩甲苯后得到油状物,用15毫升甲醇重结晶一次得到35.8克嘧菌酯,含量98.1%(外标法),收率91.7%。  In the DMF solution of o-hydroxybenzonitrile obtained in Example 5, add 32 grams (0.095mol, content 95%, provided by Shanghai Heben Pharmaceutical Industry) (E)-2-[2-(6-chloropyrimidine- 4-yloxy)phenyl]-3-methoxymethyl acrylate, 24.84 grams (0.18mol) of anhydrous potassium carbonate, heated to 50°C, stirred for one hour; then continued to heat up to 100-110°C and stirred for 5 hours , DMF was evaporated under reduced pressure, the raffinate was cooled to 80°C, 100 milliliters of toluene and 50 milliliters of water were added; the toluene phase was separated, washed successively with 20 milliliters of 5% dilute hydrochloric acid and 20 milliliters of saturated sodium bicarbonate; after concentrating the toluene, an oily The product was recrystallized once with 15 milliliters of methanol to obtain 35.8 grams of azoxystrobin, with a content of 98.1% (external standard method), and a yield of 91.7%. the

应用实施例6  Application Example 6

在实施例6中得到的邻羟基苯甲腈的DMF溶液中,加入32克(0.095mol,含量95%,上海禾本药业提供)(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯,8.28克(0.06mol)无水碳酸钾,升温到100-110℃搅拌5小时,减压蒸出DMF,残液冷却到80℃,加入100毫升甲苯和水50毫升;分出甲苯相,用20毫升5%稀盐酸和20毫升饱和碳酸氢钠依次洗涤;浓缩甲苯后得到油状物,用15毫升甲醇重结晶一次得到36.1克嘧菌酯,含量98.6%(外标法),收率93%。  In the DMF solution of o-hydroxybenzonitrile obtained in Example 6, add 32 grams (0.095mol, content 95%, provided by Shanghai Heben Pharmaceutical Industry) (E)-2-[2-(6-chloropyrimidine- 4-yloxy)phenyl]-3-methoxymethyl acrylate, 8.28 grams (0.06mol) of anhydrous potassium carbonate, heated up to 100-110°C and stirred for 5 hours, evaporated DMF under reduced pressure, and the raffinate was cooled to 80°C, add 100 ml of toluene and 50 ml of water; separate the toluene phase, wash with 20 ml of 5% dilute hydrochloric acid and 20 ml of saturated sodium bicarbonate successively; concentrate the toluene to obtain an oily substance, recrystallize once with 15 ml of methanol to obtain 36.1 Azoxystrobin, content 98.6% (external standard method), yield 93%. the

应用实施例7  Application Example 7

在实施例7中制备的邻羟基苯甲腈DMF溶液中,加入9.25克(0.1mol)环氧氯丙烷,13.8克(0.22mol)无水碳酸钾,升温到80℃搅拌3小时,冷却到室温;加入10.97克(0.15mol)叔丁胺,室温下搅拌6小时,减压蒸除过量的叔丁胺和溶剂DMF,残液加入50毫升乙酸乙酯和15毫升水;分出有机相,用30毫升饱和盐水分两次洗涤,干燥,浓缩得到粗品25.2克2-[3-(1,1-二甲基 乙基氨基)-2-羟基丙氧基]苯甲腈(布尼洛尔),再用85毫升15%氯化氢/乙醇溶液处理得到产品盐酸布尼洛尔26.4克,含量>99%(HPLC),收率91.8%。  In the o-hydroxybenzonitrile DMF solution prepared in Example 7, add 9.25 grams (0.1mol) of epichlorohydrin, 13.8 grams (0.22mol) of anhydrous potassium carbonate, heat up to 80°C and stir for 3 hours, then cool to room temperature Add 10.97 grams (0.15mol) of tert-butylamine, stir at room temperature for 6 hours, evaporate excess tert-butylamine and solvent DMF under reduced pressure, add 50 milliliters of ethyl acetate and 15 milliliters of water to the raffinate; separate the organic phase, and use 30 milliliters of saturated brine Wash twice, dry, and concentrate to obtain 25.2 grams of crude product 2-[3-(1,1-dimethylethylamino)-2-hydroxypropoxyl]benzonitrile (bunirolol), and then use 85 Milliliters of 15% hydrogen chloride/ethanol solution were treated to obtain 26.4 grams of Bunirolol hydrochloride, the content>99% (HPLC), and the yield was 91.8%. the

本发明中的实施例仅用于对本发明进行说明,并不构成对权利要求范围的限制,本领域内技术人员可以想到的其他实质上等同的替代,均在本发明保护范围内。  The embodiments in the present invention are only used to illustrate the present invention, and do not constitute a limitation to the scope of the claims. Other substantially equivalent substitutions that can be thought of by those skilled in the art are within the protection scope of the present invention. the

Claims (21)

1. the method for the DMF solution of an eco-friendly preparation salicylonitrile is characterized in that, TRIPHOSGENE 99.5 and salicylic amide is added respectively among the DMF, fully reaction.
2. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 1 is characterized in that, described salicylic amide is 1: 0.33~1.0 with the amount of substance ratio of TRIPHOSGENE 99.5.
3. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 2 is characterized in that, described salicylic amide is 1: 0.34~0.5 with the amount of substance ratio of TRIPHOSGENE 99.5.
4. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 1 is characterized in that, temperature of reaction is-20~50 ℃.
5. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 4 is characterized in that, temperature of reaction is 5~15 ℃.
6. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 1 is characterized in that, in DMF, adds TRIPHOSGENE 99.5 earlier, adds salicylic amide again.
7. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 6 is characterized in that said TRIPHOSGENE 99.5 is dissolved in inert solvent earlier, is added among the DMF again.
8. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 1 is characterized in that, in DMF, adds salicylic amide earlier, adds TRIPHOSGENE 99.5 again.
9. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 8 is characterized in that, TRIPHOSGENE 99.5 is dissolved in to add in the lump behind the inert solvent again and is dissolved with among the DMF of salicylic amide.
10. according to the method for the DMF solution of claim 7 and 9 described eco-friendly preparation salicylonitriles, it is characterized in that described inert solvent is selected from hydro carbons, ethers, ketone or ester class inert solvent.
11. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 10 is characterized in that, said hydro carbons inert solvent is selected from alkane, aromatic hydrocarbon or its substitutive derivative.
12. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 10 is characterized in that, said ethers inert solvent is selected from aliphatic ether, aromatic hydrocarbons ether or its substitutive derivative.
13. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 10 is characterized in that, said ketone inert solvent is selected from lower aliphatic ketone or its substitutive derivative.
14. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 10 is characterized in that, said ester class inert solvent is selected from fatty ester, aromatic esters or its substitutive derivative.
15. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 1 is characterized in that, after reaction is accomplished, adds the alkali neutralization, filters the DMF solution that obtains salicylonitrile.
16. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 15 is characterized in that, described alkali comprises a kind of or its mixture in mineral alkali and the organic bases.
17. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 16 is characterized in that, said mineral alkali comprises one or more in the oxide compound, oxyhydroxide, carbonate, supercarbonate of basic metal or earth alkali metal.
18. the method for the DMF solution of eco-friendly preparation salicylonitrile according to claim 16 is characterized in that said organic bases comprises one or more in triethylamine, diethylamine and the aniline.
19. the DMF solution of salicylonitrile is characterized in that, adopts the described method production of the arbitrary claim of claim 1-16.
20. salicylonitrile is characterized in that, adopts the DMF solution of the salicylonitrile of the described method production of the arbitrary claim of claim 1-16, separates obtaining salicylonitrile.
21. the application of the DMF solution of salicylonitrile in synthetic ICIA 5504 and bunitrolol.
CN201110349880.XA 2011-11-08 2011-11-08 Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril Expired - Fee Related CN102516122B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110349880.XA CN102516122B (en) 2011-11-08 2011-11-08 Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110349880.XA CN102516122B (en) 2011-11-08 2011-11-08 Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril

Publications (2)

Publication Number Publication Date
CN102516122A true CN102516122A (en) 2012-06-27
CN102516122B CN102516122B (en) 2014-11-05

Family

ID=46287258

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110349880.XA Expired - Fee Related CN102516122B (en) 2011-11-08 2011-11-08 Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril

Country Status (1)

Country Link
CN (1) CN102516122B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012205A (en) * 2012-12-26 2013-04-03 湖南海利常德农药化工有限公司 Preparation method of salicylonitrile
CN103739518A (en) * 2013-12-26 2014-04-23 安徽广信农化股份有限公司 Synthesis process for 2-hydroxybenzonitrile
CN104610095A (en) * 2015-01-04 2015-05-13 尹山红 Preparation method of o-hydroxybenzonitrile
CN106496066A (en) * 2016-09-27 2017-03-15 江苏嘉隆化工有限公司 A kind of preparation method of salicylonitrile
CN109721548A (en) * 2017-10-31 2019-05-07 南通泰禾化工股份有限公司 A kind of preparation method of Fluoxastrobin
CN112094238A (en) * 2020-09-23 2020-12-18 江苏大学 Method for post-treatment of azoxystrobin production
CN114685376A (en) * 2020-12-28 2022-07-01 北京颖泰嘉和生物科技股份有限公司 Preparation method of azoxystrobin intermediate
CN114685377A (en) * 2020-12-31 2022-07-01 北京颖泰嘉和生物科技股份有限公司 Preparation method of azoxystrobin compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101522639A (en) * 2006-10-09 2009-09-02 先正达有限公司 Preparation of azoxystrobin
CN102174002A (en) * 2011-02-28 2011-09-07 盐城工学院 Method for preparing 2-hydroxybenzonitrile from ammonium salicylate as raw material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101522639A (en) * 2006-10-09 2009-09-02 先正达有限公司 Preparation of azoxystrobin
CN102174002A (en) * 2011-02-28 2011-09-07 盐城工学院 Method for preparing 2-hydroxybenzonitrile from ammonium salicylate as raw material

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RADHIKA KUSURKAR等: "Reactions of Vilsmeier Haack reagent with aromatic and heterocyclic aldoximes", 《INDIAN JOURNAL OF CHEMISTRY》 *
WEIKE SU等: "Recent Progress in the Use of Vilsmeier-Type Reagents", 《ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL》 *
邓俊杰等: "水杨酰胺一步法合成邻羟基苯甲腈", 《山西化工》 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012205A (en) * 2012-12-26 2013-04-03 湖南海利常德农药化工有限公司 Preparation method of salicylonitrile
CN103012205B (en) * 2012-12-26 2014-10-08 湖南海利常德农药化工有限公司 Preparation method of salicylonitrile
CN103739518A (en) * 2013-12-26 2014-04-23 安徽广信农化股份有限公司 Synthesis process for 2-hydroxybenzonitrile
CN103739518B (en) * 2013-12-26 2016-03-30 安徽广信农化股份有限公司 A kind of synthesis technique of salicylonitrile
CN104610095A (en) * 2015-01-04 2015-05-13 尹山红 Preparation method of o-hydroxybenzonitrile
CN106496066A (en) * 2016-09-27 2017-03-15 江苏嘉隆化工有限公司 A kind of preparation method of salicylonitrile
CN109721548A (en) * 2017-10-31 2019-05-07 南通泰禾化工股份有限公司 A kind of preparation method of Fluoxastrobin
CN109721548B (en) * 2017-10-31 2020-11-13 南通泰禾化工股份有限公司 Preparation method of azoxystrobin
CN112094238A (en) * 2020-09-23 2020-12-18 江苏大学 Method for post-treatment of azoxystrobin production
CN114685376A (en) * 2020-12-28 2022-07-01 北京颖泰嘉和生物科技股份有限公司 Preparation method of azoxystrobin intermediate
CN114685377A (en) * 2020-12-31 2022-07-01 北京颖泰嘉和生物科技股份有限公司 Preparation method of azoxystrobin compound
CN114685377B (en) * 2020-12-31 2024-05-31 北京颖泰嘉和生物科技股份有限公司 Preparation method of azoxystrobin compound

Also Published As

Publication number Publication date
CN102516122B (en) 2014-11-05

Similar Documents

Publication Publication Date Title
CN102516122B (en) Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril
CN102627573B (en) Synthesis method for 5-aminolevulinic acid hydrochloride
CN101367760B (en) The synthetic method of 2-chloronicotinic acid
NZ570533A (en) Compounds useful as Selective androgen receptor modulators (SARM), in particular (2S)-3-(4-cyano-3-fluorophenoxy)-N-(4-cyano-3-methylphenyl)-2-hydroxy-2-methylpropionamide useful in hormonal therapy
CN114790151A (en) Composite catalytic preparation method of 2-cyano-2-methyl valproate
CN108623456A (en) The preparation method of butylphenyl phthaleine and its pharmaceutical intermediate
CN105732444A (en) Synthesis method of belinostat
CN105541714A (en) Preparation methods of papaverine and papaverine hydrochloride
CN115028596B (en) Method for preparing topramezone intermediate
CN102850347A (en) Resolution method for pyrazole derivative or salt thereof
CN104003934A (en) 6-chlorine-3-fluorine-2-picolinic acid synthesis process
CN103923040B (en) A kind of method preparing furfural oxime acid
CN106831551B (en) A kind of method that ionic liquid method synthesizes the halogenated -3- substituted hydrocarbon radical sulfonyl pyridine of 2- and its intermediate
CN104177296B (en) Preparation method of 4-(1-hydroxy-1-methyl ethyl)-2-propyl-1H-imidazole-5-carboxylic acid ethyl ester
BRPI0710882A2 (en) process for preparing a compound and compound
CN102786429A (en) Synthesis method of tolfenamic acid
ES2312162T3 (en) PROCEDURE FOR OBTAINING A SALT OF VALSARTAN USEFUL FOR THE PREPARATION OF VALSARTAN.
CN103204810B (en) A kind of tolvaptan intermediate and preparation method thereof
WO2015012271A1 (en) Method for producing heterocyclic compound
CN104761470B (en) The preparation method of (R, S)-2-[[5-(9-fluorenylmethyloxycarbonyl amino) dibenzo [a, d] cycloheptane-2-base] oxygen] acetic acid
CN103724221B (en) A kind of amide compound, its intermediate preparation method and its intermediate
CN103183643A (en) Rilpivirine intermediate and preparation method and application thereof
CN102249831B (en) New method for synthesizing 1,2,3-triaryl naphthalene derivatives
CN106866514A (en) A kind of method of the Aqueous phase synthesis substituted hydrocarbon radical sulfonyl pyridine of 2 halo 3 and its intermediate
CN109180633B (en) Purification method of atorvastatin calcium intermediate ATS-9

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 201505 Shanghai city Jinshan District Lin Po No. 2

Patentee after: SHANGHAI HEBEN PHARMACEUTICAL Co.,Ltd.

Address before: 201505 Shanghai city Jinshan District Lin Po No. 2

Patentee before: SHANGHAI HEBEN-EASTSUN MEDICAMENTS Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141105

CF01 Termination of patent right due to non-payment of annual fee